Back to today’s briefing

Story perspectives

Pharma Stocks Surge: AbbVie Leads with 32.8% Gain

10/6/2025

32 2 Full Breakdown

Summary

Story summary

Pfizer shares near a 5-year low; up 3.5% YTD, 6.4% dividend yield; 2025 earnings up 1%.
Merck down 9.3% YTD; price-to-earnings (P/E) 10; 2025 earnings up 16.7%; 3.6% dividend yield.
AbbVie up 32.8% YTD; 2025 earnings up 18.8%; P/E 19.3; 2.8% dividend yield.
Eli Lilly up 9% YTD; P/E 33; 2025 earnings up 77.3%.

1 of 1

Story summary

Pfizer shares near a 5-year low; up 3.5% YTD, 6.4% dividend yield; 2025 earnings up 1%.
Merck down 9.3% YTD; price-to-earnings (P/E) 10; 2025 earnings up 16.7%; 3.6% dividend yield.
AbbVie up 32.8% YTD; 2025 earnings up 18.8%; P/E 19.3; 2.8% dividend yield.
Eli Lilly up 9% YTD; P/E 33; 2025 earnings up 77.3%.